@article{681e80b4f8894e67adc3566b7f7068e3,
title = "Lorlatinib-induced visual and auditory hallucinations: A case report",
abstract = "Lorlatinib can cause visual and auditory hallucinations. And, it is necessary to keep in mind that hallucinations can persist even after discontinuation in patients who develop hallucinations while receiving lorlatinib.",
keywords = "Japanese patient, hallucinations, lorlatinib, nonsmall-cell lung cancer",
author = "Jun Hakamata and Hideo Nakada and Hiroshi Muramatsu and Keita Masuzawa and Hideki Terai and Shinnosuke Ikemura and Koichi Fukunaga and Tohru Aomori",
note = "Publisher Copyright: {\textcopyright} 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.",
year = "2021",
doi = "10.1002/ccr3.4040",
language = "English",
journal = "Clinical Case Reports",
issn = "2050-0904",
publisher = "John Wiley and Sons Ltd",
}
